» Articles » PMID: 28420224

Silk Fibroin-Alginate-Hydroxyapatite Composite Particles in Bone Tissue Engineering Applications In Vivo

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2017 Apr 20
PMID 28420224
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to evaluate the in vivo bone regeneration capability of alginate (AL), AL/hydroxyapatite (HA), and AL/HA/silk fibroin (SF) composites. Forty Sprague Dawley rats were used for the animal experiments. Central calvarial bone (diameter: 8.0 mm) defects were grafted with AL, AL/HA, or AL/HA/SF. New bone formation was evaluated by histomorphometric analysis. To demonstrate the immunocompatibility of each group, the level of tumor necrosis factor (TNF)-α expression was studied by immunohistochemistry (IHC) and quantitative reverse transcription polymerase chain reaction (qRT-PCR) at eight weeks post implantation. Additionally, osteogenic markers, such as fibroblast growth factor (FGF)-23, osteoprotegerin (OPG), and Runt-related transcription factor (Runx2) were evaluated by qPCR or IHC at eight weeks post implantation. The AL/HA/SF group showed significantly higher new bone formation than did the control group ( = 0.044) and the AL group ( = 0.035) at four weeks post implantation. Additionally, the AL/HA/SF group showed lower relative TNF-α mRNA levels and higher FGF-23 mRNA levels than the other groups did at eight weeks post implantation. IHC results demonstrated that the AL/HA/SF group had lower TNF-α expression and higher OPG and Runx2 expression at eight weeks post implantation. Additionally, no evidence of the inflammatory reaction or giant cell formation was observed around the residual graft material. We concluded that the AL/HA/SF composite could be effective as a scaffold for bone tissue engineering.

Citing Articles

Advances in the application and research of biomaterials in promoting bone repair and regeneration through immune modulation.

Liu L, Chen H, Zhao X, Han Q, Xu Y, Liu Y Mater Today Bio. 2025; 30():101410.

PMID: 39811613 PMC: 11731593. DOI: 10.1016/j.mtbio.2024.101410.


The Application of Regenerated Silk Fibroin in Tissue Repair.

Li Z, Tan G, Xie H, Lu S Materials (Basel). 2024; 17(16).

PMID: 39203101 PMC: 11355482. DOI: 10.3390/ma17163924.


Silk fibroin-based scaffolds for tissue engineering.

Ma L, Dong W, Lai E, Wang J Front Bioeng Biotechnol. 2024; 12:1381838.

PMID: 38737541 PMC: 11084674. DOI: 10.3389/fbioe.2024.1381838.


Degradable Polymeric Bio(nano)materials and Their Biomedical Applications: A Comprehensive Overview and Recent Updates.

Kuperkar K, Atanase L, Bahadur A, Crivei I, Bahadur P Polymers (Basel). 2024; 16(2).

PMID: 38257005 PMC: 10818796. DOI: 10.3390/polym16020206.


Advanced Applications of Silk-Based Hydrogels for Tissue Engineering: A Short Review.

Akdag Z, Ulag S, Kalaskar D, Duta L, Gunduz O Biomimetics (Basel). 2023; 8(8).

PMID: 38132551 PMC: 10742028. DOI: 10.3390/biomimetics8080612.


References
1.
Liu W, Fan J, Xu D, Zhang J, Cui Z . Epigallocatechin-3-gallate protects against tumor necrosis factor alpha induced inhibition of osteogenesis of mesenchymal stem cells. Exp Biol Med (Maywood). 2016; 241(6):658-66. PMC: 4950329. DOI: 10.1177/1535370215624020. View

2.
Roesler H . The history of some fundamental concepts in bone biomechanics. J Biomech. 1987; 20(11-12):1025-34. DOI: 10.1016/0021-9290(87)90020-0. View

3.
Tortelli F, Cancedda R . Three-dimensional cultures of osteogenic and chondrogenic cells: a tissue engineering approach to mimic bone and cartilage in vitro. Eur Cell Mater. 2009; 17:1-14. DOI: 10.22203/ecm.v017a01. View

4.
Wongputtaraksa T, Ratanavaraporn J, Pichyangkura R, Damrongsakkul S . Surface modification of Thai silk fibroin scaffolds with gelatin and chitooligosaccharide for enhanced osteogenic differentiation of bone marrow-derived mesenchymal stem cells. J Biomed Mater Res B Appl Biomater. 2012; 100(8):2307-15. DOI: 10.1002/jbm.b.32802. View

5.
Kim S, Kim M, Kweon H, Jo Y, Lee K, Lee J . Comparison of unprocessed silk cocoon and silk cocoon middle layer membranes for guided bone regeneration. Maxillofac Plast Reconstr Surg. 2016; 38(1):11. PMC: 4770059. DOI: 10.1186/s40902-016-0057-1. View